BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33945543)

  • 1. Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes.
    Mosquera Orgueira A; Ferreiro Ferro R; Díaz Arias JÁ; Aliste Santos C; Antelo Rodríguez B; Bao Pérez L; Alonso Vence N; Bendaña López Á; Abuin Blanco A; Melero Valentín P; Peleteiro Raindo AR; Cid López M; Pérez Encinas MM; González Pérez MS; Fraga Rodríguez MF; Bello López JL
    PLoS One; 2021; 16(5):e0248886. PubMed ID: 33945543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted next generation sequencing reveals high mutation frequency of
    Evrard SM; Péricart S; Grand D; Amara N; Escudié F; Gilhodes J; Bories P; Traverse-Glehen A; Dubois R; Brousset P; Parrens M; Laurent C
    Haematologica; 2019 Apr; 104(4):e154-e157. PubMed ID: 30309852
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.
    Li H; Kaminski MS; Li Y; Yildiz M; Ouillette P; Jones S; Fox H; Jacobi K; Saiya-Cork K; Bixby D; Lebovic D; Roulston D; Shedden K; Sabel M; Marentette L; Cimmino V; Chang AE; Malek SN
    Blood; 2014 Mar; 123(10):1487-98. PubMed ID: 24435047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivating mutations of acetyltransferase genes in B-cell lymphoma.
    Pasqualucci L; Dominguez-Sola D; Chiarenza A; Fabbri G; Grunn A; Trifonov V; Kasper LH; Lerach S; Tang H; Ma J; Rossi D; Chadburn A; Murty VV; Mullighan CG; Gaidano G; Rabadan R; Brindle PK; Dalla-Favera R
    Nature; 2011 Mar; 471(7337):189-95. PubMed ID: 21390126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia.
    Capello D; Vitolo U; Pasqualucci L; Quattrone S; Migliaretti G; Fassone L; Ariatti C; Vivenza D; Gloghini A; Pastore C; Lanza C; Nomdedeu J; Botto B; Freilone R; Buonaiuto D; Zagonel V; Gallo E; Palestro G; Saglio G; Dalla-Favera R; Carbone A; Gaidano G
    Blood; 2000 Jan; 95(2):651-9. PubMed ID: 10627476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.
    Morin RD; Mungall K; Pleasance E; Mungall AJ; Goya R; Huff RD; Scott DW; Ding J; Roth A; Chiu R; Corbett RD; Chan FC; Mendez-Lago M; Trinh DL; Bolger-Munro M; Taylor G; Hadj Khodabakhshi A; Ben-Neriah S; Pon J; Meissner B; Woolcock B; Farnoud N; Rogic S; Lim EL; Johnson NA; Shah S; Jones S; Steidl C; Holt R; Birol I; Moore R; Connors JM; Gascoyne RD; Marra MA
    Blood; 2013 Aug; 122(7):1256-65. PubMed ID: 23699601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma.
    Grønbaek K; Worm J; Ralfkiaer E; Ahrenkiel V; Hokland P; Guldberg P
    Blood; 2002 Aug; 100(4):1430-7. PubMed ID: 12149228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
    Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
    Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.
    Juskevicius D; Jucker D; Klingbiel D; Mamot C; Dirnhofer S; Tzankov A
    J Hematol Oncol; 2017 Mar; 10(1):70. PubMed ID: 28302137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutation in B-cell lymphoid neoplasms with reference to oncogene rearrangements associated with chromosomal translocations.
    Akasaka T; Muramatsu M; Kadowaki N; Ohno H; Ishizaki K; Yamabe H; Fukuhara S; Okuma M
    Jpn J Cancer Res; 1996 Sep; 87(9):930-7. PubMed ID: 8878455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma.
    Xian RR; Xie Y; Haley LM; Yonescu R; Pallavajjala A; Pittaluga S; Jaffe ES; Duffield AS; McCall CM; Gheith SMF; Gocke CD
    Blood Cancer J; 2020 Jun; 10(6):69. PubMed ID: 32555149
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    García-Ramírez I; Tadros S; González-Herrero I; Martín-Lorenzo A; Rodríguez-Hernández G; Moore D; Ruiz-Roca L; Blanco O; Alonso-López D; Rivas JL; Hartert K; Duval R; Klinkebiel D; Bast M; Vose J; Lunning M; Fu K; Greiner T; Rodrigues-Lima F; Jiménez R; Criado FJG; Cenador MBG; Brindle P; Vicente-Dueñas C; Alizadeh A; Sánchez-García I; Green MR
    Blood; 2017 May; 129(19):2645-2656. PubMed ID: 28288979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetic landscape of mutations in Burkitt lymphoma.
    Love C; Sun Z; Jima D; Li G; Zhang J; Miles R; Richards KL; Dunphy CH; Choi WW; Srivastava G; Lugar PL; Rizzieri DA; Lagoo AS; Bernal-Mizrachi L; Mann KP; Flowers CR; Naresh KN; Evens AM; Chadburn A; Gordon LI; Czader MB; Gill JI; Hsi ED; Greenough A; Moffitt AB; McKinney M; Banerjee A; Grubor V; Levy S; Dunson DB; Dave SS
    Nat Genet; 2012 Dec; 44(12):1321-5. PubMed ID: 23143597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer.
    Peifer M; Fernández-Cuesta L; Sos ML; George J; Seidel D; Kasper LH; Plenker D; Leenders F; Sun R; Zander T; Menon R; Koker M; Dahmen I; Müller C; Di Cerbo V; Schildhaus HU; Altmüller J; Baessmann I; Becker C; de Wilde B; Vandesompele J; Böhm D; Ansén S; Gabler F; Wilkening I; Heynck S; Heuckmann JM; Lu X; Carter SL; Cibulskis K; Banerji S; Getz G; Park KS; Rauh D; Grütter C; Fischer M; Pasqualucci L; Wright G; Wainer Z; Russell P; Petersen I; Chen Y; Stoelben E; Ludwig C; Schnabel P; Hoffmann H; Muley T; Brockmann M; Engel-Riedel W; Muscarella LA; Fazio VM; Groen H; Timens W; Sietsma H; Thunnissen E; Smit E; Heideman DA; Snijders PJ; Cappuzzo F; Ligorio C; Damiani S; Field J; Solberg S; Brustugun OT; Lund-Iversen M; Sänger J; Clement JH; Soltermann A; Moch H; Weder W; Solomon B; Soria JC; Validire P; Besse B; Brambilla E; Brambilla C; Lantuejoul S; Lorimier P; Schneider PM; Hallek M; Pao W; Meyerson M; Sage J; Shendure J; Schneider R; Büttner R; Wolf J; Nürnberg P; Perner S; Heukamp LC; Brindle PK; Haas S; Thomas RK
    Nat Genet; 2012 Oct; 44(10):1104-10. PubMed ID: 22941188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.
    O'Hayre M; Inoue A; Kufareva I; Wang Z; Mikelis CM; Drummond RA; Avino S; Finkel K; Kalim KW; DiPasquale G; Guo F; Aoki J; Zheng Y; Lionakis MS; Molinolo AA; Gutkind JS
    Oncogene; 2016 Jul; 35(29):3771-80. PubMed ID: 26616858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.
    Zhang J; Vlasevska S; Wells VA; Nataraj S; Holmes AB; Duval R; Meyer SN; Mo T; Basso K; Brindle PK; Hussein S; Dalla-Favera R; Pasqualucci L
    Cancer Discov; 2017 Mar; 7(3):322-337. PubMed ID: 28069569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the BCL-3 locus at chromosome 17q22 in B-cell neoplasms.
    Yano T; Sander CA; Andrade RE; Gauwerky CE; Croce CM; Longo DL; Jaffe ES; Raffeld M
    Blood; 1993 Sep; 82(6):1813-9. PubMed ID: 8400234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
    Okosun J; Bödör C; Wang J; Araf S; Yang CY; Pan C; Boller S; Cittaro D; Bozek M; Iqbal S; Matthews J; Wrench D; Marzec J; Tawana K; Popov N; O'Riain C; O'Shea D; Carlotti E; Davies A; Lawrie CH; Matolcsy A; Calaminici M; Norton A; Byers RJ; Mein C; Stupka E; Lister TA; Lenz G; Montoto S; Gribben JG; Fan Y; Grosschedl R; Chelala C; Fitzgibbon J
    Nat Genet; 2014 Feb; 46(2):176-181. PubMed ID: 24362818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.
    Slot LM; Hoogeboom R; Smit LA; Wormhoudt TA; Biemond BJ; Oud ME; Schilder-Tol EJ; Mulder AB; Jongejan A; van Kampen AH; Kluin PM; Guikema JE; Bende RJ; van Noesel CJ
    Am J Pathol; 2016 Dec; 186(12):3273-3284. PubMed ID: 27750045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia.
    Rossi D; Capello D; Gloghini A; Franceschetti S; Paulli M; Bhatia K; Saglio G; Vitolo U; Pileri SA; Esteller M; Carbone A; Gaidano G
    Haematologica; 2004 Feb; 89(2):154-64. PubMed ID: 15003890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.